OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - CONNECT BIOPHARMA HLDGS LTD ownership

CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 17 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of CONNECT BIOPHARMA HLDGS LTD
ValueSharesWeighting
Q3 2023$468,626
-30.1%
603,9000.0%0.01%
-42.9%
Q2 2023$670,329
+16.8%
603,900
+5.2%
0.02%
+16.7%
Q1 2023$574,148
-99.9%
574,148
-6.5%
0.02%
+20.0%
Q3 2022$792,000,000
+39.7%
613,931
-5.8%
0.02%
+87.5%
Q2 2022$567,000,000651,5060.01%
Other shareholders
CONNECT BIOPHARMA HLDGS LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 597,678$1,805,0000.60%
RA Capital Management 6,991,003$21,113,0000.46%
Ikarian Capital, LLC 677,859$2,047,0000.27%
Kynam Capital Management, LP 227,759$688,0000.22%
Octagon Capital Advisors LP 279,921$845,0000.18%
RTW INVESTMENTS, LP 446,564$1,349,0000.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,437,500$4,341,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 77,851$235,0000.01%
JANUS HENDERSON GROUP PLC 1,599,826$4,807,0000.00%
CSS LLC/IL 20,000$60,0000.00%
View complete list of CONNECT BIOPHARMA HLDGS LTD shareholders